Patent ID: 8716348
Filing Date: 2014-05-06
Classification: A61K,A61P

Abstract:
1. A packaged pharmaceutical composition, comprising: (i) formoterol, or a pharmaceutically acceptable hydrate thereof in solution; and (ii) a steroidal anti-inflammatory agent, or a pharmaceutically acceptable salt or hydrate thereof in suspension; in a pharmacologically suitable fluid comprising water that is propellant-free, wherein the composition is an aqueous composition formulated so that it is stable during long term storage, whereby the composition has an estimated shelf-life of greater than 1 month usage time at 25° C. and greater than or equal to 1 year storage time at 5° C., whereby greater than 80% of the initial amount of formoterol in the composition remains at such time; the formoterol free base concentration is about 5 μg/mL to about 118 μg/mL; and the composition is formulated at a concentration for direct administration without dilution to a human in need thereof.